Aeglea BioTherapeutics

0 followers

‌

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Headquarters

Employees

Links

Org chart

Russell J. Cox

Chief Executive Officer, Epirium Bio

Russell J. Cox

Collapse

Cortney Caudill

Chief Product Officer

Eric Bradford

Chief Development Officer

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Teams

Product Management Team

7 members

Clinical Development Team

3 members

Leadership Team

3 members

Similar companies

Kura Oncology

17 followers

REVOLUTION Medicines

5 followers

Biofourmis

4 followers

Stemline Therapeutics

3 followers

Celularity

3 followers

Pivot Bio

2 followers

Sutro Biopharma

2 followers

Quantum-Si

2 followers

EyePoint Pharmaceuticals

2 followers

Seer

4 followers

Adicet Bio

1 follower

Discover companies